期刊
MEMBRANES
卷 12, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/membranes12050532
关键词
cholesterol; lipoproteins; breast cancer; metastasis
类别
资金
- DBT, New Delhi [BT/PR30629/BIC/101/1093/2018]
- UGC [F.30-456/2018 (BSR)]
- SERB [PDF/2015/000867]
- GITAM-Research seed Grant (RSG)
Breast cancer is a common malignancy in women and a leading cause of cancer mortality. Hypercholesterolemia and obesity are potential risk factors for breast cancer incidence. Research has found a direct link between low density lipoproteins (LDL) levels and breast cancer incidence, as well as an inverse link between high density lipoproteins (HDL) and breast cancer development.
Breast cancer is one of the most common malignancies in women and the leading cause of cancer mortality. Hypercholesterolemia and obesity are potential risk factors for the incidence of breast cancer, and their detection can enhance cancer prevention. In this paper, we discuss the current state of investigations on the importance of lipoproteins, such as low denisity lipoproteins (LDL) and high density lipoproteins (HDL), and cholesterol transporters in the progression of breast cancer, and the therapeutic strategies to reduce breast cancer mortality. Although some research has been unsuccessful at uncovering links between the roles of lipoproteins and breast cancer risk, major scientific trials have found a straight link between LDL levels and incidence of breast cancer, and an inverse link was found between HDL and breast cancer development. Cholesterol and its transporters were shown to have significant importance in the development of breast cancer in studies on breast cancer cell lines and experimental mice models. Instead of cholesterol, 27-hydroxycholesterol, which is a cholesterol metabolite, is thought to promote propagation and metastasis of estrogen receptor-positive breast cancer cell lines. Alteration of lipoproteins via oxidation and HDL glycation are thought to activate many pathways associated with inflammation, thereby promoting cellular proliferation and migration, leading to metastasis while suppressing apoptosis. Medications that lower cholesterol levels and apolipoprotein A-I mimics have appeared to be possible therapeutic agents for preventing excessive cholesterol's role in promoting the development of breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据